Login / Signup

The effect of fingolimod on focal and diffuse grey matter damage in active MS patients.

Albulena BajramiMarco PitteriMarco CastellaroFrancesca PizziniChiara RomualdiStefania MontemezziSalvatore MonacoMassimiliano Calabrese
Published in: Journal of neurology (2018)
These results suggest a possible protective effect of fingolimod on focal and diffuse GM damage.
Keyphrases
  • multiple sclerosis
  • end stage renal disease
  • oxidative stress
  • ejection fraction
  • chronic kidney disease
  • low grade
  • prognostic factors
  • ms ms
  • peritoneal dialysis
  • patient reported outcomes